LILLIE LUEKE: Open Payments
NPI 1831708817 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 19 payments from 5 companies in 2025. Trend: 2023 $650 · 2024 $295 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 12 | $148 |
| UROGEN PHARMA, INC. | 4 | $91 |
| Boston Scientific Corporation | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
| COLOPLAST CORP | 1 | $16 |
Products named: ORGOVYX, JELMYTO, ZUSDURI, GEMTESA, LithoVue, BOTOX, Luja Coude.
Industry payments across NE — which companies pay providers there.
